effects of azacitidine on MDS outcome
Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR) / Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Guillermo Sanz; Alan F. List; Steven D. Gore; John F Seymour; Jay Backstrom; Linda Zimmerman; David McKenzie; C. L. Beach; and Lewis B. Silverman. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 112:(2008), pp. 3636-3636. (Intervento presentato al convegno American society of hematology).
Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR)
SANTINI, VALERIA;
2008
Abstract
effects of azacitidine on MDS outcomeFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.